Research
GLSBOR Research Collaborations
(GLSBOR). As an international scientific society, being UN & EU partner plus other international organizations support GLSBOR GLSBOR plays a crucial role in supporting and improving health systems through evidence-based tools. For achieving the following
Why Choose Research Cooperation? ❑initiatives with data-driven insights
- initiatives with data-driven insights
Strengthening Research Capacity
- Genuine, long-term partnerships
- Bridge the science-policy divide
- Empower local institutions
Access to Tools and Resources:
- Maquette for MDG Simulations: A powerful modeling tool that simulates the impact of various interventions on achieving Millennium Development Goals (MDGs).
Facilitating Evidence-Based Policy Decisions:
- By collaborating with GLSBOR, decision-makers gain access to evidence-backed recommendations. Our research informs policy design, implementation, and evaluation.
Global Impact
- Collaboration Beyond Borders
- Impact health systems worldwide
- Democratize knowledge
- Empower Authorities
1- Development Of Stroke Systems At Low And Middle Income Countries
Objectives
- Enhance Awareness: Increase public awareness about stroke risk factors, symptoms, and the importance of seeking timely medical attention.
- Capacity Building: Strengthen healthcare infrastructure by training healthcare professionals in stroke management, including neurologists, nurses, and community health workers.
- Multidisciplinary Teams: Establish multidisciplinary stroke care teams involving neurologists, rehabilitation specialists, and social workers.
- Telestroke Services: Implement telestroke programs to provide expert consultation and support to remote areas.
5-Protocol-Driven Care: Develop and implement evidence-based protocols for stroke assessment, treatment, and secondary prevention.
6-Post-Discharge Support: Focus on post-discharge care, including swallowing assessments, mobility support, and consistent secondary prevention.
7-Research and Evaluation: Continuously evaluate stroke care models, adapt strategies, and conduct research to improve outcomes in LMICs
2-Policy Analysis for Non-Communicable Diseases (NCDs) in Low- and Middle-Income Countries (LMICs):
Objectives
- Assess Current Policies: Conduct a comprehensive analysis of existing policies related to NCDs in LMICs, focusing on prevention, treatment, and management.
- Identify Gaps: Identify gaps and inconsistencies in policy frameworks, considering factors such as accessibility, equity, and cultural relevance.
- Stakeholder Engagement: Engage with key stakeholders, including governments, healthcare institutions, NGOs, and communities, to gather insights and perspectives.
- Evidence-Based Recommendations: Develop evidence-based recommendations for strengthening NCD policies, emphasizing cost-effective interventions and sustainable approaches.
.
5.Health System Integration: Propose strategies to integrate NCD prevention and management into existing health systems, ensuring continuity of care.
6.Advocacy and Awareness: Advocate for policy changes and raise awareness about NCDs, emphasizing their impact on public health and socioeconomic development.
7.Monitoring and Evaluation: Establish mechanisms for continuous monitoring, evaluation, and adaptation of NCD policies to improve outcomes and reduce the burden of NCDs in LMICs1.
Remember that addressing NCDs requires a collaborative effort across sectors, and policy analysis plays a crucial role in shaping effective interventions.
3- Enhancement Accessibility Of Rare Diseases For Innovative Medicines
Objectives
1-Equitable Access: Develop strategies to ensure equitable access to innovative medicines for individuals affected by rare diseases, regardless of their geographical location or socioeconomic status.
2-Affordability: Advocate for pricing models that make innovative treatments financially accessible to patients and sustainable for healthcare systems.
3-Regulatory Pathways: Collaborate with regulatory agencies to streamline approval processes for rare disease therapies, reducing time-to-market and ensuring timely patient access.
4-Patient-Centric Research: Prioritize patient needs and preferences in research and development, fostering patient engagement and co-design of interventions.
.
5-Global Collaboration: Facilitate international collaboration among researchers, industry, policymakers, and patient organizations to accelerate innovation and knowledge sharing.
6-Health System Integration: Integrate rare disease management into existing healthcare systems, emphasizing early diagnosis, multidisciplinary care, and long-term follow-up.
7-Evaluation and Adaptation: Continuously evaluate the impact of accessibility-enhancing initiatives and adapt strategies based on real-world outcomes1.
Addressing the unique challenges of rare diseases requires a collective effort, and these objectives aim to improve patient outcomes and quality of life.
4-Strengthening of Health Regulatory Systems in Low- and Middle-Income Countries (LMICs):
Objectives
1-Equitable Access: Develop strategies to ensure equitable access to safe and effective medicines and health technologies for all individuals in LMICs.
2-Capacity Building: Strengthen the capacity of national regulatory authorities (NRAs) to effectively regulate and oversee healthcare products.
3-Harmonization and Collaboration: Promote greater harmonization of technical standards, international cooperation, and collaboration among NRAs to streamline regulatory processes.
4-Digital Transformation: Facilitate the adoption of digital tools for regulatory processes, including product registration, surveillance, and quality control.
.
4-Digital Transformation: Facilitate the adoption of digital tools for regulatory processes, including product registration, surveillance, and quality control.
5-Evidence-Based Decision-Making: Implement evidence-based practices and data-driven decision-making to enhance regulatory efficiency and effectiveness.
6-Post-Market Surveillance: Establish robust systems for post-market surveillance, monitoring adverse events, and ensuring product safety.
7-Public Awareness and Engagement: Raise awareness among stakeholders, including healthcare professionals, policymakers, and the public, about the importance of strong regulatory systems in promoting health and safety.
Strengthening health regulatory systems is crucial for ensuring the availability, quality, and safety of healthcare products in LMICs, ultimately improving health outcomes for their populations.
5-Strengthening Health Regulatory Systems for Emerging Markets:
objectives
1-Assess Current Regulatory Landscape: Conduct an in-depth analysis of the existing regulatory systems in emerging markets. Identify gaps, challenges, and areas for improvement.
2-Benchmarking and Best Practices: Compare regulatory practices across different countries and regions. Identify successful models and best practices that can be adapted to strengthen regulatory systems.
3-Capacity Building: Develop strategies to enhance the capacity of regulatory authorities. This includes training programs, workshops, and knowledge-sharing initiatives.
4-Digital Transformation: Explore opportunities for leveraging digital technologies to streamline regulatory processes. Investigate the adoption of electronic submission systems, data analytics, and real-time monitoring.
.
5-Collaboration and Harmonization: Foster collaboration among regulatory agencies, industry stakeholders, and international organizations. Work towards harmonizing standards, guidelines, and procedures.
6-Risk Assessment and Management: Develop frameworks for assessing risks associated with new health products. Implement risk-based approaches to prioritize regulatory activities.
7-Patient Safety and Access: Ensure that regulatory reforms prioritize patient safety while facilitating timely access to quality medicines and medical devices.
6-Technology Solutions and Enhancement of Health Systems: Challenges and Opportunities:
Research objectives
1-Assess Current Health System Technologies: Conduct an in-depth analysis of existing health system technologies, including electronic health records (EHRs), telemedicine platforms, wearable devices, and mobile health applications. Evaluate their effectiveness, usability, and impact on patient care.
2-Identify Gaps and Challenges: Identify gaps and challenges in the adoption and implementation of health technologies within health systems. Explore barriers related to infrastructure, interoperability, data security, and user acceptance.
3-Evaluate Digital Health Innovations: Evaluate emerging digital health technologies such as artificial intelligence (AI), blockchain, and Internet of Things (IoT) solutions. Assess their potential to enhance health system efficiency, patient outcomes, and cost-effectiveness.
4-Develop Strategies for Integration: Develop strategies for seamless integration of technology solutions into existing health systems. Consider scalability, training requirements, and stakeholder engagement.
5-Enhance Data Analytics and Decision Support: Explore opportunities to enhance data analytics capabilities within health systems. Investigate predictive analytics, real-time monitoring, and decision support tools for healthcare professionals.
6-Address Equity and Accessibility: Investigate how technology solutions can bridge gaps in healthcare access and equity. Analyze disparities related to digital literacy, affordability, and geographical distribution.
7-Collaborate with Stakeholders: Foster collaboration among healthcare providers, policymakers, technology vendors, and patients. Engage in multi-disciplinary discussions to shape policies and guidelines for technology adoption.
7-Reshaping polices for Non Communicable Diseases at Low & Middle Income Countries
Objectives
1-Policy Landscape Assessment: Conduct a comprehensive assessment of existing policies related to NCDs in low- and middle-income countries. Identify gaps, inconsistencies, and areas for improvement.
2-Stakeholder Engagement: Engage with policymakers, healthcare professionals, community leaders, and affected individuals. Seek their input and perspectives on NCD policies to ensure inclusivity and relevance.
3-Evidence-Based Policy Recommendations: Synthesize evidence from research studies, global guidelines, and best practices. Develop evidence-based policy recommendations that address prevention, treatment, and management of NCDs.
4-Health System Strengthening: Explore strategies to enhance health systems’ capacity to manage NCDs effectively. This includes workforce training, infrastructure development, and resource allocation.
5-Equity and Access: Prioritize policies that promote equity in NCD prevention and care. Address disparities related to socioeconomic status, gender, and geographical location.
6-Behavioral Interventions: Investigate policy interventions that encourage healthy behaviors and discourage risk factors associated with NCDs. Examples include tobacco control, physical activity promotion, and healthy diet initiatives.
7-Monitoring and Evaluation: Develop mechanisms for monitoring policy implementation and evaluating their impact. Regularly assess policy effectiveness, adjust strategies as needed, and ensure accountability.
8-Reshaping Policies for Non-Communicable Diseases (NCDs) in the Middle East and North Africa (MENA) Regions:
objectives
1-Assess Current NCD Policies: Conduct a comprehensive assessment of existing NCD policies in MENA countries. Analyze their effectiveness, alignment with global guidelines, and relevance to regional health contexts.
2-Identify Policy Gaps and Inconsistencies: Identify gaps and inconsistencies in NCD policies across different MENA regions. Explore variations in implementation, enforcement, and resource allocation.
3-Evidence-Based Policy Recommendations: Develop evidence-based policy recommendations for NCD prevention, management, and control. Consider risk factors such as tobacco use, unhealthy diet, physical inactivity, and alcohol consumption.
4-Health System Strengthening: Investigate strategies to strengthen health systems’ capacity to address NCDs. This includes workforce training, infrastructure development, and integration of NCD services into primary healthcare.
5-Equity and Access: Prioritize policies that promote equity in NCD prevention and care. Address disparities related to socioeconomic status, gender, and geographical location.
6-Behavioral Interventions: Explore policy interventions to encourage healthy behaviors and discourage NCD risk factors. Examples include public awareness campaigns, taxation on unhealthy products, and workplace wellness programs.
7-Collaboration and Advocacy: Foster collaboration among policymakers, healthcare providers, researchers, and civil society organizations.
Advocate for policy changes that prioritize NCD prevention and improve population health.
Remember that reshaping NCD policies requires a holistic approach, involving multisectoral collaboration and evidence-based decision-making. These objectives aim to contribute to better health outcomes for MENA populations.
9-Policy Analysis For Depression Management At Low And Middle-Income Countries